134 related articles for article (PubMed ID: 26327508)
1. In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response.
Braun FC; van den Brandt J; Thomas S; Lange S; Schrank J; Gand C; Przybylski GK; Schmoeckel K; Bröker BM; Schmidt CA; Grabarczyk P
PLoS One; 2015; 10(9):e0135444. PubMed ID: 26327508
[TBL] [Abstract][Full Text] [Related]
2. A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression.
Song XT; Evel-Kabler K; Shen L; Rollins L; Huang XF; Chen SY
Nat Med; 2008 Mar; 14(3):258-65. PubMed ID: 18311150
[TBL] [Abstract][Full Text] [Related]
3. A20 expression in dendritic cells protects mice from LPS-induced mortality.
Xuan NT; Wang X; Nishanth G; Waisman A; Borucki K; Isermann B; Naumann M; Deckert M; Schlüter D
Eur J Immunol; 2015 Mar; 45(3):818-28. PubMed ID: 25472594
[TBL] [Abstract][Full Text] [Related]
4. Regulation of NF-κB- and STAT1-mediated plasmacytoid dendritic cell functions by A20.
Duy PN; Thuy NT; Trang BK; Giang NH; Van NTH; Xuan NT
PLoS One; 2019; 14(9):e0222697. PubMed ID: 31545817
[TBL] [Abstract][Full Text] [Related]
5. Attenuated A20 expression of acute myeloid leukemia-derived dendritic cells increased the anti-leukemia immune response of autologous cytolytic T cells.
Zhang X; Su Y; Song H; Yu Z; Zhang B; Chen H
Leuk Res; 2014 Jun; 38(6):673-81. PubMed ID: 24713261
[TBL] [Abstract][Full Text] [Related]
6. Mucosal and systemic anti-HIV immunity controlled by A20 in mouse dendritic cells.
Hong B; Song XT; Rollins L; Berry L; Huang XF; Chen SY
J Clin Invest; 2011 Feb; 121(2):739-51. PubMed ID: 21206085
[TBL] [Abstract][Full Text] [Related]
7. Interplay of Toll-Like Receptor 9, Myeloid Cells, and Deubiquitinase A20 in Periodontal Inflammation.
Crump KE; Oakley JC; Xia-Juan X; Madu TC; Devaki S; Mooney EC; Sahingur SE
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27849177
[TBL] [Abstract][Full Text] [Related]
8. Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response.
Srivastav S; Kar S; Chande AG; Mukhopadhyaya R; Das PK
J Immunol; 2012 Jul; 189(2):924-34. PubMed ID: 22685311
[TBL] [Abstract][Full Text] [Related]
9. Activation of the human immune system via toll-like receptors by the oncolytic parvovirus H-1.
Sieben M; Schäfer P; Dinsart C; Galle PR; Moehler M
Int J Cancer; 2013 Jun; 132(11):2548-56. PubMed ID: 23151948
[TBL] [Abstract][Full Text] [Related]
10. Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20.
Xia M; Liu J; Wu X; Liu S; Li G; Han C; Song L; Li Z; Wang Q; Wang J; Xu T; Cao X
Immunity; 2013 Sep; 39(3):470-81. PubMed ID: 24012418
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.
Boone DL; Turer EE; Lee EG; Ahmad RC; Wheeler MT; Tsui C; Hurley P; Chien M; Chai S; Hitotsumatsu O; McNally E; Pickart C; Ma A
Nat Immunol; 2004 Oct; 5(10):1052-60. PubMed ID: 15334086
[TBL] [Abstract][Full Text] [Related]
12. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
[TBL] [Abstract][Full Text] [Related]
13. Chaetoglobosin F, a small molecule compound, possesses immunomodulatory properties on bone marrow-derived dendritic cells via TLR9 signaling pathway.
Hua C; Yang Y; Sun L; Dou H; Tan R; Hou Y
Immunobiology; 2013 Mar; 218(3):292-302. PubMed ID: 22739238
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium fortuitum induces A20 expression that impairs macrophage inflammatory responses.
Lee GJ; Lee HM; Kim TS; Kim JK; Sohn KM; Jo EK
Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26940588
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection.
Liuwantara D; Elliot M; Smith MW; Yam AO; Walters SN; Marino E; McShea A; Grey ST
Diabetes; 2006 Sep; 55(9):2491-501. PubMed ID: 16936197
[TBL] [Abstract][Full Text] [Related]
16. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
Heo MB; Cho MY; Lim YT
Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17 (IL-17)-induced microRNA 873 (miR-873) contributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin-editing enzyme.
Liu X; He F; Pang R; Zhao D; Qiu W; Shan K; Zhang J; Lu Y; Li Y; Wang Y
J Biol Chem; 2014 Oct; 289(42):28971-86. PubMed ID: 25183005
[TBL] [Abstract][Full Text] [Related]
18. The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity.
Ahn YH; Hong SO; Kim JH; Noh KH; Song KH; Lee YH; Jeon JH; Kim DW; Seo JH; Kim TW
Clin Exp Immunol; 2015 Jul; 181(1):164-78. PubMed ID: 25753156
[TBL] [Abstract][Full Text] [Related]
19. A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells.
Gon Y; Asai Y; Hashimoto S; Mizumura K; Jibiki I; Machino T; Ra C; Horie T
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):330-6. PubMed ID: 15142865
[TBL] [Abstract][Full Text] [Related]
20. Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
Charan RA; Hanson R; Clemens PR
FASEB J; 2012 Feb; 26(2):587-95. PubMed ID: 22012122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
